Super Crop Safe Ltd.

Chemicals · Fertilizers & Agrochemicals

BSE: 530883
₹13.23
▼ -0.23 (-1.71%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
35/100
Weak
Valuation
78/100
Undervalued
Momentum
48/100
Neutral

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹53 Cr
PE (TTM)
22.8
Industry median 14.0 (38 companies)
Price to Book
1.7
PEG (TTM)
0.7
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-33.2
Free Cash Flow
₹3 Cr
as of March 31, 2026
Industry median ₹1 Cr (51 companies)
EPS Growth (YoY)
166.67%
as of June 30, 2026
Industry median 11.34% (47 companies)
Net Profit Growth (TTM)
-15.59%
as of June 30, 2026
Industry median 13.05% (46 companies)
Operating Revenue Growth (TTM)
51.30%
as of June 30, 2026
Industry median 4.42% (46 companies)
Profit Growth (YoY)
80.06%
as of Sept. 30, 2024
Industry median 11.58% (46 companies)
Revenue Growth (YoY)
96.49%
as of June 30, 2026
Industry median -1.79% (46 companies)
Current Ratio
2.52
as of March 31, 2026
Industry median 1.55 (49 companies)
Debt to Equity
1.33
as of March 31, 2026
Industry median 0.32 (48 companies)
Interest Coverage
2.70
as of June 30, 2026
Industry median 4.24 (48 companies)
Net Margin
2.03%
as of Dec. 31, 2025
Industry median 6.16% (48 companies)
Operating Margin (EBIT)
8.62%
as of June 30, 2026
Industry median 9.73% (48 companies)
Operating Margin (TTM)
5.52%
as of June 30, 2026
Industry median 8.58% (48 companies)
Return on Assets
2.49%
as of March 31, 2026
Industry median 4.14% (47 companies)
Return on Capital Employed
4.52%
as of March 31, 2026
Industry median 11.17% (47 companies)
Return on Equity
7.10%
as of March 31, 2026
Industry median 7.44% (47 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (1.33)
  • No Return on equity is 15% or more (7.1%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 2 met
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.7%
Low 12.8100 · High 13.5900
1W return
-2.5%
Low 12.8100 · High 14.0000
1M return
-8.6%
Low 12.2600 · High 14.8500
52W return
-43.5%
Low 12.2600 · High 15.9000
Lifetime High ₹171.1000 (Nov. 14, 2017)
Lifetime Low ₹4.6000 (March 31, 2023)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
13.4
10D
13.5
20D
13.6
50D
13.7
100D
13.9
200D
14.4

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

13.21
Pivot
First resistance13.61
Second resistance13.99
Third resistance14.39
First support12.83
Second support12.43
Third support12.05
Day RSI44.6
Day MFI48.9
Day MACD-0.14
Day MACD signal-0.14

Beta

1M-0.80
3M-0.62
1Y-0.62
3Y0.46

Price change analysis

↓ -8.6%
Over 1 Month
LowHigh
12.2614.85
↓ -43.5%
Over 3 Months
LowHigh
12.2615.90
↓ -43.5%
Over 6 Months
LowHigh
12.2615.90
↓ -43.5%
Over 1 Year
LowHigh
12.2615.90
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 22.8 (own history: 23.9–86.7)
Undervalued (below its own historical PE range)
Revenue (June 30, 2026)
₹19 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹0.3200

Ranks #37 of 44 in Fertilizers & Agrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter32.21%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 32.36% to 32.21% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
24 Dec 2024 KAUSHIK SHAH SHARES & SEC. LTD Bulk Sell 203,308 19.6100 BSE
24 Dec 2024 KAUSHIK SHAH SHARES & SEC. LTD Bulk Buy 203,308 23.4000 BSE
24 Dec 2024 BANSRAJ GOND Bulk Buy 455,210 22.9700 BSE
24 Dec 2024 BANSRAJ GOND Bulk Sell 455,210 20.3600 BSE
14 Oct 2024 ELAN VENTURES PRIVATE LIMITED Bulk Sell 216,182 21.4500 BSE
14 Oct 2024 ELAN VENTURES PRIVATE LIMITED Bulk Buy 220,293 21.0900 BSE
17 Sep 2024 KUNVARJI ENTERPRISE LLP Bulk Sell 202,833 14.9200 BSE
7 Aug 2023 KUNVARJI ENTERPRISE LLP Bulk Buy 400,000 8.1100 BSE
30 Dec 2022 SHUBHAM FINANCIAL SERVICES Bulk Sell 888 7.8000 BSE
30 Dec 2022 SHUBHAM FINANCIAL SERVICES Bulk Buy 225,888 7.8100 BSE

All bulk and block deals →

Corporate Announcements

All 3 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Super Crop Safe Ltd - 530883 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Super Crop Safe Ltd - 530883 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Insider Trading / SAST Super Crop Safe Ltd - 530883 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 2.52)
  • Strong revenue growth YoY (96.5%)

Weaknesses

  • Low Return on Equity (7.1%)
  • Thin net profit margin (2.0%)
  • High financial leverage (Debt/Equity 1.33)

Opportunities

  • PEG below 1 (0.72) -- earnings growth outpacing its own valuation

Threats

  • Down 43.5% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Super Crop Safe Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.